Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (8): 805-806.DOI: 10.3969/j.issn.1673-8640.2023.08.019
Received:
2022-06-26
Revised:
2022-11-06
Online:
2023-08-30
Published:
2023-10-30
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.08.019
[1] | 张时民. 血液分析仪多参数浮动均值质控法的实验研究[J]. 检验医学, 2007, 22(4):490-493. |
[2] | 王莹, 单洪丽, 曲林琳. 血常规MCHC对标本性状异常的提示价值及抗干扰方案的探讨[J]. 国际检验医学杂志, 2022, 43(3):285-289. |
[3] | 宫丹, 李薇, 胡亮钉, 等. 中国t(8;21)AML患者临床特征及预后分析:一项多中心回顾性研究[J]. 中国实验血液学杂志, 2017, 25(4):980-986. |
[4] | 宫丹, 王铭宏, 于力. t(8;21)急性髓性白血病诊断分层研究进展[J]. 中国实验诊断学, 2015(12):2144-2147. |
[5] | 王平, 彭贤贵, 陈幸华, 等. AML1/ETO+融合基因阳性的AML患者骨髓细胞形态学分析[J]. 重庆医学, 2010, 39(12):1503-1504. |
[6] | 钟万芬, 乐家新. 血细胞分析仪检测中MCHC假性增高的原因及处理方法[J]. 现代检验医学杂志, 2008, 23(6):127. |
[7] | 肖振霞, 焦连亭, 徐士欣. 红细胞内血红蛋白浓度平均值在鉴别脂浊对血红蛋白浓度测定影响的探讨[J]. 检验医学, 2005, 20(5):444. |
[8] | 张春莹, 陈姣, 黄茜, 等. 由1例血常规漏检病例引起的思考[J]. 检验医学, 2018, 33(3):273-274. |
[9] | 罗丽, 祝先进, 施鹏冲, 等. 红细胞参数在慢性粒细胞白血病慢性期患者诊断和治疗反应性预测中的价值[J]. 检验医学与临床, 2022, 19(9):1177-1180. |
[10] | 朱建锋, 潘柏申. 血片红细胞形态学检查在疾病诊断中的应用[J]. 检验医学与临床, 2013,(23):3211-3212. |
[11] | 王庚, 赵天赐, 张小江, 等. 外周血涂片检出马尔尼菲蓝状菌2例[J]. 临床检验杂志, 2019, 37(1):75-76. |
[12] | 赵冬梅. 血细胞形态学漏检致误诊1例分析[J]. 临床合理用药杂志, 2015, 8(17):72. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||